Republic Healthcare Limited (HK:8357)

:8357

8357

Republic Healthcare Limited

RESEARCH TOOLSreports

Want to see HK:8357 full AI Analyst Report?

Republic Healthcare Limited (8357) Price & Analysis

0 Followers

8357 Stock Chart & Stats

HK$0.12

HK$0.00(0.00%)

At close: Jan 03 4:00 PM EST

HK$0.12

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.07 - HK$0.24

Previous CloseN/A

Volume50.00K

Average Volume (3M)282.67K

Market Cap

HK$76.13M

Enterprise ValueHK$10.99M

Total Cash (Recent Filing)HK$9.75M

Total Debt (Recent Filing)HK$1.25M

Price to Earnings (P/E)―

Beta0.27

Next Earnings

Jul 31, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding624,000,000

10 Day Avg. Volume457,500

30 Day Avg. Volume282,666

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)1.51

Price to Sales (P/S)1.84

P/FCF Ratio-4.63

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative Pre-2025 LeverageA multi-year record of low leverage through 2021–2024 implies the company historically maintained financial flexibility and creditor confidence. That track record increases the likelihood management can access capital or negotiate covenants during a turnaround, cushioning multi-month shocks.

Sizeable Equity Base Vs AssetsA meaningful equity buffer relative to assets supports solvency under stress and provides runway for restructuring without immediate liquidation. Sustained equity capacity reduces short-to-medium-term bankruptcy risk and allows time for operational fixes or asset reallocation.

Demonstrated Ability To Generate Cash HistoricallyPositive operating and free cash flow in 2023–2024 shows the business can generate cash under the right conditions. That historical cash conversion suggests management has levers (pricing, utilization, cost control) that could be redeployed to restore cash generation over a multi-month recovery horizon.

Bears Say

Worsening Profitability And Revenue DeclineConsecutive double-digit revenue declines and a shift to a gross loss indicate structural pressure on demand, pricing or cost absorption. Persistent margin erosion reduces reinvestment capacity and makes achieving scale economics harder, lengthening any required operational turnaround.

Negative And Volatile Cash GenerationRecurrent swings between positive and negative operating/free cash flow show weak cash conversion and planning visibility. Sustained negative cash flow forces reliance on external financing, increases refinancing risk, and constrains working capital and capex needed to stabilize operations over months.

Material Increase In Debt In 2025A notable jump in debt while losses deepen raises interest and covenant pressure, reducing strategic flexibility. Elevated leverage during a loss-making period heightens refinancing and solvency risk and may compel dilutive capital raises or asset disposals if cash generation does not recover.

8357 FAQ

What was Republic Healthcare Limited’s price range in the past 12 months?

Republic Healthcare Limited lowest stock price was HK$0.07 and its highest was HK$0.24 in the past 12 months.

What is Republic Healthcare Limited’s market cap?

Republic Healthcare Limited’s market cap is HK$76.13M.

When is Republic Healthcare Limited’s upcoming earnings report date?

Republic Healthcare Limited’s upcoming earnings report date is Jul 31, 2026 which is in 87 days.

How were Republic Healthcare Limited’s earnings last quarter?

Republic Healthcare Limited released its earnings results on Mar 26, 2026. The company reported -HK$0.017 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.017.

Is Republic Healthcare Limited overvalued?

According to Wall Street analysts Republic Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Republic Healthcare Limited pay dividends?

Republic Healthcare Limited does not currently pay dividends.

What is Republic Healthcare Limited’s EPS estimate?

Republic Healthcare Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Republic Healthcare Limited have?

Republic Healthcare Limited has 624,000,000 shares outstanding.

What happened to Republic Healthcare Limited’s price movement after its last earnings report?

Republic Healthcare Limited reported an EPS of -HK$0.017 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.759%.

Which hedge fund is a major shareholder of Republic Healthcare Limited?

Currently, no hedge funds are holding shares in HK:8357

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Republic Healthcare Limited Stock Smart Score

Underperform

Technicals

Fundamentals

Return on Equity

-27.01%

Trailing 12-Months

Asset Growth

18.49%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Republic Healthcare Limited

Republic Healthcare Limited, a primary healthcare services company, provides consultation, medical investigation, and treatment services in Singapore. The company offers various treatment solutions for common medical conditions and focuses on sexual health and infectious diseases. It also provides treatment solutions for common skin conditions and basic medical aesthetics services. The company operates nine clinics under the Dr. Tan & Partners brand name; and one clinic under the S Aesthetics brand name. Republic Healthcare Limited was founded in 2010 and is headquartered in Singapore.